My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 103

    1.

    Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer : A Prostate Cancer Clinical Trials Consortium trial.

    Ross RW, Galsky MD, Febbo P, Barry M, Richie JP, Xie W, Fennessy FM, Bhatt RS, Hayes J, Choueiri TK, Tempany CM, Kantoff PW, Taplin ME, Oh WK.

    Cancer. 2012 Jan 26. doi: 10.1002/cncr.27416. [Epub ahead of print]

    PMID:
    22282219
    [PubMed - as supplied by publisher]

    Related citations

    2.

    Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy.

    Zafarana G, Ishkanian AS, Malloff CA, Locke JA, Sykes J, Thoms J, Lam WL, Squire JA, Yoshimoto M, Ramnarine VR, Meng A, Ahmed O, Jurisca I, Milosevic M, Pintilie M, van der Kwast T, Bristow RG.

    Cancer. 2012 Jan 26. doi: 10.1002/cncr.26729. [Epub ahead of print]

    PMID:
    22281794
    [PubMed - as supplied by publisher]

    Related citations

    3.

    Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and younger.

    Hoppe BS, Nichols RC, Henderson RH, Morris CG, Williams CR, Costa J, Marcus RB Jr, Mendenhall WM, Li Z, Mendenhall NP.

    Cancer. 2012 Jan 17. doi: 10.1002/cncr.27398. [Epub ahead of print]

    PMID:
    22253020
    [PubMed - as supplied by publisher]

    Related citations

    4.

    Explaining racial differences in prostate cancer mortality.

    Taksler GB, Keating NL, Cutler DM.

    Cancer. 2012 Jan 13. doi: 10.1002/cncr.27379. [Epub ahead of print]

    PMID:
    22246942
    [PubMed - as supplied by publisher]

    Related citations

    5.

    Active surveillance for prostate cancer compared with immediate treatment: An economic analysis.

    Keegan KA, Dall'era MA, Durbin-Johnson B, Evans CP.

    Cancer. 2011 Dec 16. doi: 10.1002/cncr.26688. [Epub ahead of print]

    PMID:
    22180322
    [PubMed - as supplied by publisher]

    Related citations

    6.

    Efficacy of peripheral androgen blockade in prostate cancer patients with biochemical failure after definitive local therapy: Results of Cancer and Leukemia Group B (CALGB) 9782.

    Monk JP, Halabi S, Picus J, Hussain A, Philips G, Kaplan E, Ahles T, Gu L, Vogelzang N, Kelly WK, Small EJ; for the Cancer and Leukemia Group B.

    Cancer. 2011 Dec 16. doi: 10.1002/cncr.26732. [Epub ahead of print]

    PMID:
    22180287
    [PubMed - as supplied by publisher]

    Related citations

    7.

    Statin use and fatal prostate cancer: A matched case-control study.

    Marcella SW, David A, Ohman-Strickland PA, Carson J, Rhoads GG.

    Cancer. 2011 Dec 16. doi: 10.1002/cncr.26720. [Epub ahead of print]

    PMID:
    22180145
    [PubMed - as supplied by publisher]

    Related citations

    8.

    How does health literacy affect quality of life among men with newly diagnosed clinically localized prostate cancer?: Findings from the North Carolina-Louisiana Prostate Cancer Project (PCaP).

    Song L, Mishel M, Bensen JT, Chen RC, Knafl GJ, Blackard B, Farnan L, Fontham E, Su LJ, Brennan CS, Mohler JL, Godley PA.

    Cancer. 2011 Dec 16. doi: 10.1002/cncr.26713. [Epub ahead of print]

    PMID:
    22180041
    [PubMed - as supplied by publisher]

    Related citations

    9.

    The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy.

    Cooperberg MR, Hilton JF, Carroll PR.

    Cancer. 2011 Nov 15;117(22):5039-46. doi: 10.1002/cncr.26169. Epub 2011 Jun 3.

    PMID:
    21647869
    [PubMed - indexed for MEDLINE]

    Related citations

    10.

    Androgen deprivation for prostate cancer: The case for "first, do no harm"

    Shahinian VB.

    Cancer. 2011 Nov 9. doi: 10.1002/cncr.26624. [Epub ahead of print] No abstract available.

    PMID:
    22072504
    [PubMed - as supplied by publisher]

    Related citations

    11.

    Androgen deprivation and thromboembolic events in men with prostate cancer.

    Ehdaie B, Atoria CL, Gupta A, Feifer A, Lowrance WT, Morris MJ, Scardino PT, Eastham JA, Elkin EB.

    Cancer. 2011 Nov 9. doi: 10.1002/cncr.26623. [Epub ahead of print]

    PMID:
    22072494
    [PubMed - as supplied by publisher]

    Related citations

    12.

    Whole-gland salvage high-intensity focused ultrasound therapy for localized prostate cancer recurrence after external beam radiation therapy.

    Ahmed HU, Cathcart P, Chalasani V, Williams A, McCartan N, Freeman A, Kirkham A, Allen C, Chin J, Emberton M.

    Cancer. 2011 Nov 9. doi: 10.1002/cncr.26631. [Epub ahead of print]

    PMID:
    22071795
    [PubMed - as supplied by publisher]

    Related citations

    13.

    Reverse stage shift at a tertiary care center: escalating risk in men undergoing radical prostatectomy.

    Silberstein JL, Vickers AJ, Power NE, Fine SW, Scardino PT, Eastham JA, Laudone VP.

    Cancer. 2011 Nov 1;117(21):4855-60. doi: 10.1002/cncr.26132. Epub 2011 Apr 11.

    PMID:
    21484780
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    14.

    Utilization and expense of adjuvant cancer therapies following radical prostatectomy.

    Spencer B.

    Cancer. 2011 Nov 1;117(21):4810-1. doi: 10.1002/cncr.26008. Epub 2011 Apr 11. No abstract available.

    PMID:
    21484778
    [PubMed - indexed for MEDLINE]

    Related citations

    15.

    Utilization and expense of adjuvant cancer therapies following radical prostatectomy.

    Williams SB, Gu X, Lipsitz SR, Nguyen PL, Choueiri TK, Hu JC.

    Cancer. 2011 Nov 1;117(21):4846-54. doi: 10.1002/cncr.26012. Epub 2011 Mar 1.

    PMID:
    21365630
    [PubMed - indexed for MEDLINE]

    Related citations

    16.

    Castration-resistant prostate cancer: Many treatments, many options, many challenges ahead.

    Garcia JA, Rini BI.

    Cancer. 2012 May 15;118(10):2583-93. doi: 10.1002/cncr.26582. Epub 2011 Oct 28.

    PMID:
    22038761
    [PubMed - in process]

    Related citations

    17.

    Costs of medical care after open or minimally invasive prostate cancer surgery: A population-based analysis.

    Lowrance WT, Eastham JA, Yee DS, Laudone VP, Denton B, Scardino PT, Elkin EB.

    Cancer. 2011 Oct 24. doi: 10.1002/cncr.26609. [Epub ahead of print]

    PMID:
    22025192
    [PubMed - as supplied by publisher]

    Related citations

    18.

    Impact of race on survival in patients with clinically nonmetastatic prostate cancer who deferred primary treatment.

    Koscuiszka M, Hatcher D, Christos PJ, Rose AE, Greenwald HS, Chiu YL, Taneja SS, Mazumdar M, Lee P, Osman I.

    Cancer. 2011 Oct 21. doi: 10.1002/cncr.26619. [Epub ahead of print]

    PMID:
    22020835
    [PubMed - as supplied by publisher]

    Related citations

    19.

    Selective detection of histologically aggressive prostate cancer: An Early Detection Research Network Prediction model to reduce unnecessary prostate biopsies with validation in the Prostate Cancer Prevention Trial.

    Williams SB, Salami S, Regan MM, Ankerst DP, Wei JT, Rubin MA, Thompson IM, Sanda MG.

    Cancer. 2012 May 15;118(10):2651-8. doi: 10.1002/cncr.26396. Epub 2011 Oct 17.

    PMID:
    22006057
    [PubMed - in process]

    Related citations

    20.

    Prostate cancer in the elderly: Frequency of advanced disease at presentation and disease-specific mortality.

    Scosyrev E, Messing EM, Mohile S, Golijanin D, Wu G.

    Cancer. 2011 Oct 17. doi: 10.1002/cncr.26392. [Epub ahead of print]

    PMID:
    22006014
    [PubMed - as supplied by publisher]

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filters: Manage Filters

      Find related data

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk